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ABSTRACT
Electrospray ionisation mass spectrometry (ESI-MS), absorption spectrophotometry and
circular dichroism spectroscopy were used to investigate the non-covalent binding
interactions of the nickel complexes [Ni(phen)2(L)]Cl2, (L = phen, dpq ,dpqc and dppz)
with the 16mer oligonucleotide D2, which has the following base sequence:
(GCTGCCAAATACCTCC/GGAGGTATTTGGCAGC).

In addition,

the extent of

unwinding of the negatively supercoiled plasmid pUC9 caused by the nickel complexes,
and the extent to which they inhibit in vitro synthesis of mRNA, were investigated using
gel electrophoresis. The results of these studies showed that DNA binding strengthened as
the size of the unique ligand was increased. Comparison of each of the above sets of results
with those obtained from identical experiments performed using the analogous ruthenium
complexes [Ru(phen)2(L)]2+ (L = phen, dpq, dpqc, dppz) showed that varying the metal ion
had a measurable effect on DNA binding affinity, with the nickel complexes generally
interacting more weakly with D2 than the corresponding ruthenium complexes.
ESI-MS/MS and in-source collision-induced dissociation experiments were performed
using the tetrameric quadruplex DNA molecule Q5 (TTGGGGGT)4 and antiparallel
dimeric quadruplex Q2 (GGGGTTTTGGGG)2 in order to determine their gas-phase
dissociation profiles. It was found that the gas phase stability of the quadruplex DNA was
dependent on its charge state, the number of oligonucleotide strands that make up the
quadruplex, and the number of consecutive G-tetrads that it contains. ESI-MS and circular
dichroism spectroscopy were also used to examine the non-covalent binding interactions of
the octahedral nickel and ruthenium complexes stated above, as well as several square
planar platinum

complexes

with

Q5.

The platinum

complexes

studied

were
iv

[Pt(en)(phen)]2+, [Pt(en)(3,4,7,8-Me4phen)]2+, [Pt(en)(4,7-Me2phen)]2+ and

[Pt(5,6-

Me2phen)(S,S-dach)]2+. The results obtained from these experiments showed that each of
the three groups of metal complexes were able to bind to Q5. In contrast to what was found
in experiments involving the duplex DNA molecule D2, the presence of the intercalating
dppz ligand in the coordination sphere of both the nickel and ruthenium complexes did not
greatly increase their binding affinity towards quadruplex DNA. This observation suggests
that intercalative binding interactions may not play as important a role in the binding of
metal complexes to quadruplex DNA. ESI-MS was used to analyse mixtures containing the
organic drug daunomycin, Q5, and either [Ru(phen)2(dppz)]2+ or [Pt(en)(4,7-Me2phen)]2+,
in order to obtain information about the qDNA binding modes of these metal complexes.
The affinity of the above two metal complexes towards parallel tetrameric quadruplexes
with different lengths was also compared using ESI-MS in an attempt to shed light on
whether they bind to the ends of the quadruplexes or in grooves along their lengths.
The optimal conditions required to obtain ESI mass spectra of the non-covalent adduct
formed between the DNA binding domain of mouse transcription factor PU.1, and a short
10mer DNA molecule containing its 5'-GGAA-3' consensus sequence, were determined.
ESI-MS was then used to probe the extent of inhibition of formation of this non-covalent
complex caused by addition of [Ru(phen)2(dppz)]2+ or [Pt(5,6-Me2phen)(S,S-dach)]2+.
Both metal complexes were shown to inhibit binding of the transcription factor to its DNA
recognition site, demonstrating the potential of these complexes for transcription therapy.
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ABBREVIATIONS
A

adenine

AML

acute myeloid leukemia

bip

biphenyl

Bqdi

1,2-benzoquinone diimine

Bpy

bipyridine

C

cytosine

CD

circular dichroism

CI

chemical ionisation

CID

collision induced dissociation

CT-DNA

calf thymus DNA

Dach

1,2-diaminocyclohexane

DCM

dichloromethane

DMB

4,4’-dimethyl-2,2’-bipyridine

DNA

deoxyribonucleic acid

dppm

1,2-bis(diphenylphosphino)methane

dppz

dipyrido[3,2-a:2',3'-c]phenazine

dpq

dipyrido[3,2-d-2',3'-f]quinoxaline

dpqc

dipyrido[3,2-a:2',3'-c](6,7,8,9-tetrahydrophenazine)

dsDNA

double-stranded DNA

DTC

diethylthiocarbocyanide

EDTA

ethylenediaminetetraacetic acid

EGR1

early growth response factor 1
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EI

electron ionisation

en

(1,2-diaminoethane)

ESI

electrospray ionisation

FAB

fast atom bombardment

FD

field desorption

FDA

food and drug administration

G

guanine

GSH

glutathione

GST

glutathione-S-transferase

HAT

1,4,5,8,9,12-hexaazatriphenylene

HIF-1

hypoxia inducible factor 1α

IκB

inhibitor of κB

ICD

induced circular dichroism

MALDI

matrix assisted laser desorption ionisation

MGP

4-(guanidylmethyl)-1-10-phenanthroline

MOPS

3-(N-morpholino)propanesulfonic acid

MS

mass spectrometry

m/z

mass-to-charge

NF-κB

nuclear factor-κB

NH4OAc

ammonium acetate

NMR

nuclear magnetic resonance

PD

plasma desorption

phi

9,10-phenanthrenequinone diimine

phen

1,10-phenanthroline
vii

Q-TOF

quadrupole time-of-flight

qDNA

quadruplex DNA

RNA

ribonucleic acid

R,R-Me2trien

2R,9R-diamino-4,7-diazadecane

Sp1

Specficity Protein 1

Stat3

Signal transducer and activator of transcription

T

thymine

TBACl

tetrabutylammonium chloride

terpy

2,2:6’2’’-terpyridine

TFOs

triplex forming oligonucleotides

TMPyP4

[tetra(N-methyl-4-pyridyl-porphine)]

tpphz

tetrapyridophenazine

yAP-1

yeast Activator Protein 1
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